Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group

Diabetologia
Lutz HeinemannAnne L Peters

Abstract

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes. However, even with modern insulin pumps, errors of insulin infusion can occur due to pump failure, insulin infusion set (IIS) blockage, infusion site problems, insulin stability issues, user error or a combination of these. Users are therefore exposed to significant and potentially fatal hazards: interruption of insulin infusion can result in hyperglycaemia and ketoacidosis; conversely, delivery of excessive insulin can cause severe hypoglycaemia. Nevertheless, the available evidence on the safety and efficacy of CSII remains limited. The European Association for the Study of Diabetes (EASD) and American Diabetes Association (ADA) have therefore joined forces to review the systems in place for evaluating the safety of pumps from a clinical perspective. We found that useful information held by the manufacturing companies is not currently shared in a sufficiently transparent manner. Public availability of adverse event (AE) reports on the US Food and Drug Administration's Manufacturer and User Facility Device Experience (MAUDE) database is...Continue Reading

References

Jan 28, 1978·British Medical Journal·J C PickupK G Alberti
Jun 27, 2006·Diabetes & Metabolism·I GuilhemD Maugendre
Jul 2, 2009·Pediatric Diabetes·S E HoferUNKNOWN DPV-Science-Initiative and the German working group for insulin pump treatment in pediatric patients
Jun 11, 2010·Diabetes Technology & Therapeutics·David M MaahsH Peter Chase
Feb 16, 2012·The New England Journal of Medicine·Daniel B KramerAaron S Kesselheim
Aug 28, 2012·Journal of Diabetes Science and Technology·Lutz Heinemann, Lars Krinelke
Sep 22, 2012·The Journal of Clinical Endocrinology and Metabolism·Roy W BeckUNKNOWN T1D Exchange Clinic Network
Mar 6, 2013·Diabetes Technology & Therapeutics·John Pickup
Jun 25, 2013·The New England Journal of Medicine·Richard M BergenstalUNKNOWN ASPIRE In-Home Study Group
Aug 21, 2013·Pediatric Diabetes·Meredith S CampbellUNKNOWN T1D Exchange Clinic Network
May 13, 2014·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·George GrunbergerCaitlin Rothermel

❮ Previous
Next ❯

Citations

Feb 18, 2016·Diabetes Technology & Therapeutics·Lutz Heinemann
Jun 30, 2015·Journal of Diabetes·Anna R MauriziUNKNOWN C.S.I.I. Study Group of Lazio Region Italy
Jul 16, 2016·Pediatric Diabetes·Agnieszka SzypowskaUNKNOWN SWEET Study Group
Sep 23, 2016·Molecular Pharmaceutics·Bhagyesh R SarodeSimon H Friedman
Nov 12, 2016·Diabetes Technology & Therapeutics·Agathe GuenegoIsabelle Guilhem
Jun 13, 2018·Advanced Materials·Ali K YetisenHaider Butt
Jun 26, 2018·Journal of Forensic Sciences·Andrew ZieglerElizabeth A Bundock
Sep 25, 2017·Diabetologia·Miriam CnopMischa van Eimeren
Oct 20, 2018·Artificial Organs·Ralf SchielAntje Steveling
Mar 26, 2019·Pharmaceutical Nanotechnology·Fatemah BahmanSebastien Taurin
Jul 17, 2019·Contact Dermatitis·Anne Herman, An Goossens
Apr 25, 2017·Assessment·Paul S StrandJessica L Beaver
Jul 10, 2019·Journal of Evaluation in Clinical Practice·Margaret HarrisKatharine Steinbeck
Nov 7, 2019·Current Diabetes Reports·Simon H Friedman
Dec 14, 2019·American Journal of Therapeutics·Revital NimriMoshe Phillip
Sep 22, 2015·The Journal of Clinical Endocrinology and Metabolism·Signe RosenlundSteen Andersen
Jan 26, 2017·Anesthesiology·Elizabeth W DugganGuillermo E Umpierrez
Nov 26, 2016·Diabetic Medicine : a Journal of the British Diabetic Association·I RabboneUNKNOWN Italian Paediatric Pump Failure Study Group
Sep 9, 2016·Journal of Diabetes Science and Technology·Guido FreckmannBettina Petersen
Feb 24, 2017·Diabetes Technology & Therapeutics·Federico BertuzziFabio Garuti
Apr 24, 2018·Clinical Diabetes and Endocrinology·I Hodish
Sep 16, 2017·Current Diabetes Reports·Carlos E Mendez, Guillermo E Umpierrez
Jan 27, 2015·Diabetologia·Viktor JörgensPierre Lefèbvre
Sep 29, 2020·Pediatric Diabetes·Eileen R FauldsMary Beth Happ
Mar 25, 2021·Journal of Medical Internet Research·Claudia EberleMaxine Löhnert
May 7, 2021·Journal of the European Academy of Dermatology and Venereology : JEADV·A HermanUNKNOWN ESCD, EECDRG, EADV Contact Dermatitis Task Force, EAACI
Jul 16, 2021·Pediatric Annals·Walter PalmerRochelle Naylor
Jul 24, 2021·Journal of Diabetes Science and Technology·Eileen R FauldsKathleen Dungan
Dec 2, 2017·Journal of the American Chemical Society·Karthik Nadendla, Simon H Friedman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.